Cite
HARVARD Citation
Ruffatti, A. et al. (2016). Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study. Journal of reproductive immunology. pp. 14-19. [Online].